Philip R. Greipp

44.7k total citations · 9 hit papers
323 papers, 28.4k citations indexed

About

Philip R. Greipp is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Philip R. Greipp has authored 323 papers receiving a total of 28.4k indexed citations (citations by other indexed papers that have themselves been cited), including 235 papers in Hematology, 171 papers in Molecular Biology and 125 papers in Oncology. Recurrent topics in Philip R. Greipp's work include Multiple Myeloma Research and Treatments (227 papers), Cancer Treatment and Pharmacology (69 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (60 papers). Philip R. Greipp is often cited by papers focused on Multiple Myeloma Research and Treatments (227 papers), Cancer Treatment and Pharmacology (69 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (60 papers). Philip R. Greipp collaborates with scholars based in United States, Canada and United Kingdom. Philip R. Greipp's co-authors include Robert A. Kyle, S. Vincent Rajkumar, Morie A. Gertz, Rafaël Fonseca, John A. Lust, Martha Q. Lacy, Angela Dispenzieri, Thomas E. Witzig, Shaji Kumar and Stephen J. Russell and has published in prestigious journals such as New England Journal of Medicine, Advanced Materials and The Journal of Experimental Medicine.

In The Last Decade

Philip R. Greipp

320 papers receiving 27.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International Staging System for Multiple Myeloma

2005 1.9k citations Philip R. Greipp, Robert A. Kyle et al. Journal of Clinical Oncology profile →
Improved survival in multiple myeloma and the impact of novel therapies

2007 1.7k citations Shaji Kumar, S. Vincent Rajkumar et al. Blood profile →
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

2003 1.6k citations Robert A. Kyle, Morie A. Gertz et al. Mayo Clinic Proceedings profile →
Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

2012 730 citations Shaji Kumar, Angela Dispenzieri et al. Journal of Clinical Oncology profile →
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

2009 673 citations S. Vincent Rajkumar, Rafaël Fonseca et al. profile →
Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis

2004 639 citations Angela Dispenzieri, Morie A. Gertz et al. Journal of Clinical Oncology profile →
Phase III Clinical Trial of Thalidomide Plus Dexamethasone Compared With Dexamethasone Alone in Newly Diagnosed Multiple Myeloma: A Clinical Trial Coordinated by the Eastern Cooperative Oncology Group

2005 637 citations S. Vincent Rajkumar, Emily Blood et al. Journal of Clinical Oncology profile →
Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

2003 621 citations Rafaël Fonseca, Philip R. Greipp et al. profile →
Amyloidosis (AL). Clinical and laboratory features in 229 cases.

1983 449 citations Robert A. Kyle, Philip R. Greipp PubMed profile →

Peers

Countries citing papers authored by Philip R. Greipp

Since Specialization

Citations

This map shows the geographic impact of Philip R. Greipp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip R. Greipp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip R. Greipp more than expected).

Fields of papers citing papers by Philip R. Greipp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip R. Greipp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip R. Greipp. The network helps show where Philip R. Greipp may publish in the future.

Co-authorship network of co-authors of Philip R. Greipp

This figure shows the co-authorship network connecting the top 25 collaborators of Philip R. Greipp. A scholar is included among the top collaborators of Philip R. Greipp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip R. Greipp. Philip R. Greipp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Importance of Achieving Stringent Complete Response After Autologous Stem-Cell Transplantation in Multiple Myeloma 2013 ·Journal of Clinical Oncology ·Prashant Kapoor, Shaji Kumar, Angela Dispenzieri, Martha Q. Lacy, Francis K. Buadi, David Dingli, Stephen J. Russell, Suzanne R. Hayman, Thomas E. Witzig, John A. Lust, Nelson Leung, Yi Lin, Steven R. Zeldenrust, Arleigh McCurdy, Philip R. Greipp, Robert A. Kyle, S. Vincent Rajkumar, Morie A. Gertz	120
2	Species D Adenoviruses as Oncolytics against B-cell Cancers 2011 ·Clinical Cancer Research ·Christopher Y. Chen, Julien S. Senac, Eric A. Weaver, Shannon M. May, Diane F. Jelinek, Philip R. Greipp, Thomas E. Witzig, Michael A. Barry	37
3	Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: Results from a phase 2 trial 2011 ·American Journal of Hematology ·Shaji Kumar, Martha Q. Lacy, Suzanne R. Hayman, Keith Stewart, Francis K. Buadi, Jacob B. Allred, Kristina Laumann, Philip R. Greipp, John A. Lust, Morie A. Gertz, Steven R. Zeldenrust, P. Leif Bergsagel, Craig B. Reeder, Thomas E. Witzig, Rafaël Fonseca, Stephen J. Russell, Joseph Mıkhael, David Dingli, S. Vincent Rajkumar, Angela Dispenzieri	44
4	Narrative Review: Clarkson Disease-Systemic Capillary Leak Syndrome 2010 ·Annals of Internal Medicine ·Kirk M. Druey, Philip R. Greipp	5
5	Recent Improvements in Survival in Primary Systemic Amyloidosis and the Importance of an Early Mortality Risk Score 2010 ·Mayo Clinic Proceedings ·Shaji Kumar, Morie A. Gertz, Martha Q. Lacy, David Dingli, Suzanne R. Hayman, Francis K. Buadi, (unknown), Steven R. Zeldenrust, Nelson Leung, Philip R. Greipp, John A. Lust, Stephen J. Russell, Robert A. Kyle, S. Vincent Rajkumar, Angela Dispenzieri	124
6	Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma 2009 ·Journal of Clinical Oncology ·Martha Q. Lacy, Suzanne R. Hayman, Morie A. Gertz, Angela Dispenzieri, Francis K. Buadi, Shaji Kumar, Philip R. Greipp, John A. Lust, Stephen J. Russell, David Dingli, Robert A. Kyle, Rafaël Fonseca, P. Leif Bergsagel, Vivek Roy, Joseph Mıkhael, A. Keith Stewart, Kristina Laumann, Jacob B. Allred, Sumithra J. Mandrekar, S. Vincent Rajkumar	226
7	Infection and Killing of Multiple Myeloma by Adenoviruses 2009 ·Human Gene Therapy ·Julien S. Senac, Konstantin Doronin, Stephen J. Russell, Diane F. Jelinek, Philip R. Greipp, Michael A. Barry	41
8	Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney 2009 ·Nephrology Dialysis Transplantation ·Morie A. Gertz, Nelson Leung, M. Q. Lacy, Angela Dispenzieri, Steven R. Zeldenrust, S. R. Hayman, Francis K. Buadi, (unknown), Philip R. Greipp, Shaji Kumar, John A. Lust, S. Vincent Rajkumar, Stephen J. Russell, T. E. Witzig	82
9	Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling 2007 ·Cancer Research ·Wee Joo Chng, Shaji Kumar, Scott VanWier, Greg Ahmann, Tammy Price-Troska, (unknown), Tae‐Hoon Chung, Seungchan Kim, George Mulligan, Barbara M. Bryant, John D. Carpten, Morie A. Gertz, S. Vincent Rajkumar, Martha Q. Lacy, Angela Dispenzieri, Robert A. Kyle, Philip R. Greipp, P. Leif Bergsagel, Rafaël Fonseca	195
10	Treatment Paradigms for the Newly Diagnosed Patient With Multiple Myeloma 2005 ·Seminars in Hematology ·Philip R. Greipp	2
11	Clinical Course of Patients With Relapsed Multiple Myeloma 2004 ·Mayo Clinic Proceedings ·Shaji Kumar, Terry M. Therneau, Morie A. Gertz, Martha Q. Lacy, Angela Dispenzieri, S. Vincent Rajkumar, Rafaël Fonseca, Thomas E. Witzig, John A. Lust, Dirk R. Larson, Robert A. Kyle, Philip R. Greipp	266
12	Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival 2003 ·Blood ·Anne J. Novak, Jaime Darce, Bonnie K. Arendt, Brandon Harder, Katherine Henderson, Wayne Kindsvogel, Jane A. Gross, Philip R. Greipp, Diane F. Jelinek	422
13	Bone marrow angiogenesis and circulating plasma cells in multiple myeloma 2003 ·British Journal of Haematology ·Shaji Kumar, Thomas E. Witzig, Philip R. Greipp, S. Vincent Rajkumar	21
14	Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study. 2002 ·PubMed ·Rafaël Fonseca, David Harrington, Martin M. Oken, Gordon W. Dewald, Richard J. Bailey, Scott A. Van Wier, Kimberly J. Henderson, Emily Blood, S. Vincent Rajkumar, Neil E. Kay, Brian Van Ness, Philip R. Greipp	139
15	Systemic therapy of myeloma xenografts by an attenuated measles virus 2001 ·Blood ·Kah-Whye Peng, Gregory Ahmann, Linh Pham, Philip R. Greipp, Roberto Cattaneo, Stephen J. Russell	159
16	A Prospective Study of CD38/45 Flow Cytometry and Immunofluorescence Microscopy to Detect Blood Plasma Cells in Patients with Plasma Cell Proliferative Disorders 2000 ·Leukemia & lymphoma ·Thomas E. Witzig, (unknown), Terry M. Therneau, Philip R. Greipp	5
17	Paclitaxel as the Initial Treatment of Multiple Myeloma 1998 ·American Journal of Clinical Oncology ·(unknown), Traci Leong, Janardan D. Khandekar, Philip R. Greipp, Morie A. Gertz, Robert A. Kyle	19
18	Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 cases 1998 ·British Journal of Haematology ·Rafaël Fonseca, Thomas E. Witzig, Morie A. Gertz, Robert A. Kyle, James D. Hoyer, Syed M. Jalal, Philip R. Greipp	59
19	Detection of monoclonal plasma cells in the peripheral blood of patients with primary amyloidosis 1998 ·British Journal of Haematology ·Edwin McElroy, Thomas E. Witzig, Morie A. Gertz, Philip R. Greipp, Robert A. Kyle	10
20	Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia. 1990 ·The Journal of Experimental Medicine ·M Adachi, Ayalew Tefferi, Philip R. Greipp, Thomas J. Kipps, Yuji Tsujimoto	139

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact